DePuy Synthes Reports 1Q19 Revenue of $2,203MM, -2.1% vs. 1Q18

DePuy Synthes reported 1Q19 orthopaedic revenue of USD $2,203MM, -2.1% vs. 1Q18.

Knee sales were impacted by competitive pressure in the U.S. coupled with declines in EMEA, which were partially offset by increasing uptake of ATTUNE Revision
Hip sales were supported by strong market demand for the ACTIS stem

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us